CTI BioPharma Corp.

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Other
HZNPHorizon Therapeutics Plc 0.84%70.745.6%$170.13m
VRXValeant Pharmaceuticals International, Inc. -0.08%19.6714.1%$115.74m
CTLTCatalent, Inc. -3.23%99.992.1%$103.06m
BHCBausch Health Cos., Inc. -0.08%19.670.0%$82.53m
JAZZJazz Pharmaceuticals Plc 0.94%144.452.4%$79.42m
UTHRUnited Therapeutics Corp. 0.61%136.8514.1%$67.06m
GWPHGW Pharmaceuticals Plc 0.14%125.006.1%$64.00m
PRGOPerrigo Co. Plc 0.15%48.186.8%$54.56m
SAGESAGE Therapeutics, Inc. 2.65%78.208.6%$41.45m
ICLRICON plc -1.06%187.674.2%$38.03m
ARGXargenx SE -0.62%267.670.0%$37.40m
SAVACassava Sciences, Inc. -1.64%7.210.0%$35.42m
BLRXBioLineRx Ltd. -12.57%2.311.8%$31.95m
AMRNAmarin Corp. Plc -2.71%4.501.5%$31.65m
PCRXPacira Biosciences, Inc. -1.09%65.5410.0%$30.87m

Company Profile

CTI BioPharma Corp. is a biopharmaceutical company, which focuses on the development, acquisition and commercialization of novel targeted therapies for blood-related cancers. It focuses on evaluating pacritinib, its sole product candidate currently in active development, for the treatment of adult patients with myelofibrosis. The company was founded by James A. Bianco, Jack W. Singer, and Louis A. Bianco in September 1991 and is headquartered in Seattle, WA.